Table 2. Dose Adjustment with Renal Dysfunction.
Visit (Time) | SCr ≤ 2 mg/dl | SCr > 2, but ≤ 3 mg/dl | SCr > 3, but < 5 mg/dl | SCr ≥ 5 mg/dl |
---|---|---|---|---|
0 (Baseline)* | 300 mg | 100 mg | Excluded | Excluded |
1 (7-10 Days)*† | 600 mg | 300 mg | --- | --- |
2 (4 Weeks)‡ | 600 mg | 300 mg | 100 mg | Discontinue |
4 (12 Weeks)‡ | 600 mg | 300 mg | 100 mg | Discontinue |
SCr, serum creatinine level.
Screening laboratories used to determine dosing at baseline and visit 1;
laboratories are not checked at this visit, which is a telephone call;
if renal function improves at visit 2 or 4, subjects remain at established dose (i.e., no up-titration).